Glenmark Pharmaceuticals informs about disclosure

01 Dec 2020 Evaluate
Glenmark Pharmaceuticals has informed that the company has issued a notice of optional redemption to the holders of $200 million 4.5% Senior Notes due 2021 (Notice) listed on the Singapore Exchange Securities Trading Limited, in accordance with the terms of the Indenture dated as of August 1, 2016 (as amended, supplemented, waived or otherwise modified from time to time), between, among others, the Company and Citicorp International, as trustee. Copy of the Notice is attached.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

954.95 -8.05 (-0.84%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.